Pages that link to "Q40879293"

The following pages link to Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. (Q40879293):

Displaying 18 items.

• Cilastatin attenuates cisplatin-induced proximal tubular cell damage (Q24309247) (← links)
• Mechanisms of Cisplatin nephrotoxicity (Q26996320) (← links)
• Membrane transporters as mediators of Cisplatin effects and side effects (Q30446860) (← links)
• Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study. (Q34748754) (← links)
• Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase (Q36445285) (← links)
• Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1 (Q37096494) (← links)
• The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity (Q37138812) (← links)
• Klotho has dual protective effects on cisplatin-induced acute kidney injury (Q37678608) (← links)
• Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology (Q38333066) (← links)
• Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 (Q38702252) (← links)
• Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells. (Q38736332) (← links)
• Xenobiotic transporters and kidney injury (Q39098252) (← links)
• Dinuclear alkylamine platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): influence of endocytosis and copper and organic cation transport systems on cellular uptake (Q40246535) (← links)
• Megalin mediates renal uptake of heavy metal metallothionein complexes. (Q41166644) (← links)
• Functional impairment of renal organic cation transport in experimental diabetes (Q44036373) (← links)
• On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent. (Q48363596) (← links)
• Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors (Q48687653) (← links)
• Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity (Q50074885) (← links)